Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

0
Player Avatar foolstracker (78.28) Submitted: 4/11/2010 5:35:34 PM : Outperform Start Price: $2.74 CLRT Score: +71.76

stock of the day

Featured Broker Partners


Advertisement